Because sinularin seems to be more effective against SKBR3 (HER2+ type) than MDA-MB-231 (triple-negative type) breast cancer cells, we chose the SKBR3 cells to further examine their cytotoxic mechanisms in the following. The gene discussed is ERBB2; the disease is breast cancer.